Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development. Their unique assays, such as Tox Tracker and Repro Tracker, enable clients to make informed decisions on compound safety, thereby contributing to the development of better medicines and reducing reliance on animal testing. Toxys serves a diverse clientele, including pharmaceutical, chemical, and consumer goods companies, and is recognized for its mechanistic understanding of toxicity, which enhances regulatory compliance and safety assessments.
Something looks off?